Endometriosis and assisted reproductive technologies: maximizing outcomes

Area of Science:

• Reproductive Medicine
• Infertility Treatment
• Endometriosis Management

Background:

• Endometriosis is a common cause of infertility.
• In vitro fertilization (IVF) is a primary treatment for endometriosis-related infertility.
• Pelvic anatomy and peritoneal environment issues in endometriosis are bypassed by IVF.

Purpose of the Study:

• To evaluate the impact of endometriosis on IVF cycle outcomes.
• To assess the efficacy of surgical and medical interventions for endometriosis in IVF.
• To determine if IVF ovarian stimulation affects endometriosis progression.

Main Methods:

• Review of contemporary outcomes data for IVF in patients with endometriosis.
• Analysis of the effect of ovarian endometriomas on gonadotropin response and implantation.
• Evaluation of surgical ablation (superficial and deep infiltrative) and medical therapies (GnRH agonists, aromatase inhibitors, danazol, oral contraceptives) prior to IVF.

Main Results:

• IVF cycle outcomes are generally not compromised by endometriosis when controlled for age.
• Ovarian endometriomas may lead to a poorer response to gonadotropin therapy but don't clearly affect implantation rates.
• Surgical resection of ovarian endometriomas may negatively impact ovarian reserve; pre-cycle GnRH agonist therapy may benefit a subset of patients with advanced disease or implantation failure.

Conclusions:

• IVF is an effective treatment for endometriosis-related infertility, bypassing anatomical and environmental challenges.
• Surgical intervention for endometriosis, particularly ovarian endometrioma resection, should be carefully considered due to potential negative effects on ovarian reserve.
• Further research is needed to identify patient subsets benefiting from pre-cycle medical interventions like GnRH agonists.